Strategy of Metal-Polymer Composite Stent To Accelerate Biodegradation of Iron-Based Biomaterials.
Yongli QiHaiping QiYao HeWenjiao LinPeize LiLi QinYiwen HuLiping ChenQingsong LiuHongtao SunQiong LiuGui ZhangShuquan CuiJun HuLin YuDeyuan ZhangJiandong DingPublished in: ACS applied materials & interfaces (2017)
The new principle and technique to tune biodegradation rates of biomaterials is one of the keys to the development of regenerative medicine and next-generation biomaterials. Biodegradable stents are new-generation medical devices applied in percutaneous coronary intervention, etc. Recently, both corrodible metals and degradable polymers have drawn much attention in biodegradable stents or scaffolds. It is, however, a dilemma to achieve good mechanical properties and appropriate degradation profiles. Herein, we put forward a metal-polymer composite strategy to achieve both. Iron stents exhibit excellent mechanical properties but low corrosion rate in vivo. We hypothesized that coating of biodegradable aliphatic polyester could accelerate iron corrosion due to the acidic degradation products, etc. To demonstrate the feasibility of this composite material technique, we first conducted in vitro experiments to affirm that iron sheet corroded faster when covered by polylactide (PLA) coating. Then, we fabricated three-dimensional metal-polymer stents (MPS) and implanted the novel stents in the abdominal aorta of New Zealand white rabbits, setting metal-based stents (MBS) as a control. A series of in vivo experiments were performed, including measurements of residual mass and radial strength of the stents, histological analysis, micro-computed tomography, and optical coherence tomography imaging at the implantation site. The results showed that MPS could totally corrode in some cases, whereas iron struts of MBS in all cases remained several months after implantation. Corrosion rates of MPS could be easily regulated by adjusting the composition of PLA coatings.
Keyphrases
- computed tomography
- percutaneous coronary intervention
- drug delivery
- iron deficiency
- magnetic resonance imaging
- optical coherence tomography
- coronary artery disease
- aortic valve
- acute myocardial infarction
- magnetic resonance
- mass spectrometry
- working memory
- risk assessment
- pulmonary arterial hypertension
- pulmonary artery
- coronary artery
- left ventricular
- antiplatelet therapy
- photodynamic therapy
- health risk assessment